Suppr超能文献

通过局部应用N-甲基-N-亚硝基脲和N-丁基-N-(3-羧丙基)亚硝胺在异位膀胱中诱导肿瘤。

Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine.

作者信息

Oyasu R, Iwasaki T, Matsumoto M, Hirao Y, Tabuchi Y

出版信息

Cancer Res. 1978 Sep;38(9):3019-25.

PMID:679209
Abstract

The heterotopic urinary bladder with a communicating reservoir is a potentially useful model for bladder carcinogenesis studies. As a test of whether such bladders will develop transitional cell carcinomas after chronic carcinogenic stimuli, two carcinogens, N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine, were instilled repeatedly into the reservoir connected with the heterotopic bladder. Transitional cell carcinomas developed in 25 of 33 heterotopic bladders exposed to cumulative doses of 1.5, 3.0, or 6.0 mg of N-methyl-N-nitrosourea for between 20 and 30 weeks, while heterotopic bladders exposed to cumulative doses of 150 or 300 mg of N-butyl-N-(3-carboxypropyl)nitrosamine failed to develop tumors. However, 11 of 27 rats with heterotopic bladders that were exposed to N-butyl-N-(3-carboxypropyl)nitrosamine for over 20 weeks developed tumors in their homotopic or natural bladders. N-Methyl-N-Nitrosourea probably acted directly on the bladder epithelial cells to induce neoplastic change. The reason(s) for the development of tumors in homotopic but not heterotopic bladders when N-butyl-N-(3-carboxypropyl)nitrosamine was administered directly into the heterotopic bladders could not be ascertained from these studies.

摘要

带有连通储器的异位膀胱是膀胱致癌作用研究中一种潜在有用的模型。为了测试这种膀胱在慢性致癌刺激后是否会发生移行细胞癌,将两种致癌物,即N-甲基-N-亚硝基脲和N-丁基-N-(3-羧丙基)亚硝胺,反复注入与异位膀胱相连的储器中。在20至30周内接受累积剂量为1.5、3.0或6.0毫克N-甲基-N-亚硝基脲的33个异位膀胱中,有25个发生了移行细胞癌,而接受累积剂量为150或300毫克N-丁基-N-(3-羧丙基)亚硝胺的异位膀胱未发生肿瘤。然而,在27只异位膀胱大鼠中,有11只在接受N-丁基-N-(3-羧丙基)亚硝胺处理超过20周后,其原位或天然膀胱发生了肿瘤。N-甲基-N-亚硝基脲可能直接作用于膀胱上皮细胞以诱导肿瘤性改变。从这些研究中无法确定当直接将N-丁基-N-(3-羧丙基)亚硝胺注入异位膀胱时,原位膀胱而非异位膀胱发生肿瘤的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验